78
Participants
Start Date
January 31, 2006
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Sunitinib
50mg daily, taken by mouth for 28 days followed by 2 weeks of drug free period was one cycle. Cycles were repeated until progression of disease or unacceptable toxicity was observed
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Kwei-Shan
Pfizer Investigational Site, Genova
Pfizer Investigational Site, Ancona
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Nanjing
Pfizer Investigational Site, Guangzhou
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Hong Kong
Pfizer Investigational Site, Shatin
Pfizer Investigational Site, Kashiwa
Pfizer Investigational Site, Suntougun
Pfizer Investigational Site, Chuo-ku
Pfizer Investigational Site, Porto
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY